Company intelligence / Profile preview

Klarisana

San Antonio, Texas, United Statesklarisana.com ↗

Ownership: Private
Development stage: Other

Overview

Klarisana operates a network of mental health clinics specializing in ketamine-assisted psychotherapy and FDA-approved esketamine nasal spray therapy. The company reports strong improvement scores among patients with treatment-resistant depression, PTSD, anxiety, and chronic pain. Clinical results cited include rapid symptom relief and reduced relapse rates for patients using Spravato (esketamine), consistent with published data from Janssen Pharmaceuticals. Thousands of patients have been treated since the company's founding in 2015.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecule (ketamine, esketamine)Device (nasal spray for Spravato)
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Klarisana.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klarisana.

Explore the full profile